Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 3 I, 2000, Pages 865-872

  Kirk, O ^a   Gatell, J M ^a   Mocroft, A ^a   Pedersen, C ^a   Proenca, R ^a   Brettle, R P ^a   Barton, S E ^a   Sudre, P ^a   Phillips, A N ^a   Lundgren, J D ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

EID: 0033833932     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.3.9908018     Document Type: Article

References (30)

1. Changing patterns of mortality across Europe in patients infected with HIV-1: EuroSIDA Study Group
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators
3. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres: Federation National des Centres de Lutte contre le SIDA
4. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration: Multicenter AIDS Cohort Study Investigators
5. AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment
6. Natural history of HIV infection in the era of combination antiretroviral therapy
7. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals: Multicenter AIDS Cohort Study
8. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons: Adult/Adolescent Spectrum of HIV Disease Project Group
9. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection: Royal Free/Chelsea and Westminster Hospitals Collaborative Group
10. Tuberculosis among European patients with the acquired immune deficiency syndrome: The AIDS in Europe Study Group
11. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome
12. Disseminated Mycobacterium avium complex disease in the Swiss HIV Cohort Study: Increasing incidence, unchanged prognosis
13. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
14. Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy
15. Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients: EuroSIDA Study Group
16. Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine: AIDS in Europe Study Group
17. Changes in use of antiretroviral therapy in regions of Europe over time: EuroSIDA Study Group
18. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS
19. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS: International MAC Study Group
20. Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland: Swiss HIV Cohort Study
21. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study
22. Outcome and predictors of failure of highly active antiretroviral therapy: One-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons
23. Incidence of tuberculosis in the United States among HIV-infected persons: The Pulmonary Complications of HIV Infection Study Group
24. Disseminated Mycobacterium avium complex infection: Clinical identification and epidemiologic trends
25. The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs
26. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
27. An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1
28. Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis
29. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease